The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus. But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

Six of the reports have been in the U.S. About 80,000 doses of Ixchiq have been distributed globally and the CDC said the most serious issues have been in people with underlying chronic conditions.

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...